. During the last decade, gastric inhibitory polypeptide, now commonly referred to as glucose-dependent insulinotrophic polypeptide (GIP) , has been recognized as the main incretinlike peptide (Creutzfeldt 1979; Pederson & Brown 1976; Ebert et al. 1979 ). However, it has been claimed from experiments in animals and man that 'incretins' other than GIP do exist. Creutzfeldt (1979) and Ebert et al. (1979) have tested the role of GIP as an incretin using an immunochemical approach and have shown that infusion with a potent GIP antiserum in rats does not abolish the late incretin effect of GIP released by hydrochloric acid. Studies by Levin et al. (1979 Levin et al. ( , 1980 on insulin release following perfusion of an isolated rat pan¬ creas with the portal venous effluent of a perfused rat gastrointestinal tract, also suggested the exi¬ stence of a distinct insulinotrophic substance secre¬ ted by the intestine.
It is apparent from the investigation in man by Sarson et al. (1982) Fig. 1 . A dose response increase in portal insulinaemia was obtained after bolus injections of increasing doses of GIP (Fig. 2) . Cation exchange chromatography of the starting material. In order to isolate the fraction constituted by neutral peptides, the starting material was submit¬ ted to partial purification using cation-exchange chromatography (Fig. 4) . The eluted fractions were tested on the in situ rat pancreas preparation and Fig. 3 . Preparative electrofocusing of the starting material: aliquot fractions injected in the in situ rat pancreas revealed three pH areas which exhibited an insulinotrophic activity. Fig. 4 ).
the composition of the active fractions was eva¬ luated by preparative electrofocusing. Although the yield of this separation step was small because of the difficulty in separating the neutral insulino¬ trophic fraction from GIP, this method did allow the isolation of a group of active fractions contain¬ ing only peptides with an isoelectric point close to pH 7.0. We shall refer to these peptides as the neutral insulinotrophic fraction.
Gel chromatography of the neutral insulinotrophic fraction In order to evaluate the molecular weight (MW) of this (these) active neutral factor(s), the neutral fraction was eluted on a G-50 superfine gel in the presence of three labelled peptides: insulin (MW5734), glucagon (MW 3483) and LRH (MW 1 182). The active fraction eluted just before insulin (Fig. 5) suggesting that its apparent MW is slightly higher than that of insulin.
Incubation of the neutral fraction with bovine trypsin resulted in suppression of its biological activity.
The concentration of GIP-like immunoreactivity in the neutral insulinotrophic fraction, was found to be below 20 fmol^g. Analysis of the same frac¬ tion by reversed phase liquid chromatography did not reveal any GIP content (Fig. 6) .
In addition to testing with the in situ rat pancreas preparation, the insulinotrophic effect of the active fraction was also verified using an isolated rat pancreas preparation (Fig. 7a and b) . The results show that the activity of the neutral insulinotrophic factor is glucose-dependent. In the presence of 5.5 mM glucose, the active peptide doubled insulin output, which increased from approximately 3 ng/ min to 8 ng/min. Insulin production in the pre¬ sence of 10.0 mM glucose was approximately 20 ng/ min and was also doubled by perfusion with the active peptide. (Creutzfeldt 1979; Ebert et al. 1979 (1981) .
The low cross-reactivity in the GIP radioimmuno¬ assay, which was shown to be highly specific (Sarson et al. 1980) suggests that this neutral peptide is not a GIP-structure related peptide, and is probably different from the high molecular form of GIP.
In conclusion, the present observation suggests the existence, in the porcine duodenum, of an incretin activity different from that of the insulino¬ trophic factors already reported.
